Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412.

Jean-Pascal Machiels, Yungan Tao, Barbara Burtness, Makoto Tahara, Lisa Licitra, Danny Rischin, John Waldron, Christian Simon, Vincent Gregoire, Kevin Harrington, Gustavo Vasconcelos Alves, Iane Pinto Figueiredo Lima, Yoann Pointreau, Brett G. M Hughes, Sercan Aksoy, Marcin Hetnal, Joy Y. Ge, Holly Brown, Jonathan Cheng, Behzad BidadiLillian L. Siu

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412.'. Together they form a unique fingerprint.

Medicine & Life Sciences